Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Valentina Peta"'
Autor:
Pauline Maisonnasse, Thierry Poynard, Mehdi Sakka, Sepideh Akhavan, Romain Marlin, Valentina Peta, Olivier Deckmyn, Nesrine Braham Ghedira, Yen Ngo, Marika Rudler, Sylvie van der Werf, Stephane Marot, Dominique Thabut, Harry Sokol, Chantal Housset, Alain Combes, Roger Le Grand, Patrice Cacoub
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 3, Pp 393-402 (2022)
Background and Aims: Apolipoprotein A1 (A1) and haptoglobin (HP) serum levels are associated with the spread and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We have constructed and validated a multivariable ris
Externí odkaz:
https://doaj.org/article/d512ccbd6fe74ee2be66d77c0226a4b7
Autor:
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, Valentina Peta, Sepideh Akhavan, Fabien Zoulim, Victor de Ledinghen, Didier Samuel, Philippe Mathurin, Vlad Ratziu, Dominique Thabut, Chantal Housset, Hélène Fontaine, Stanislas Pol, Fabrice Carrat
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 4, Pp 604-617 (2022)
Background and Aims: The liver cancer risk test (LCR1-LCR2) is a multianalyte blood test combining proteins involved in liver cell repair (apolipoprotein A1, haptoglobin), hepatocellular carcinoma (HCC) risk factors (gender, age, gamma glutamyl trans
Externí odkaz:
https://doaj.org/article/fe0797793ffb4609867fca065acaaac8
Autor:
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, Valentina Peta, Sepideh Akhavan, Victor de Ledinghen, Fabien Zoulim, Didier Samuel, Philippe Mathurin, Vlad Ratziu, Dominique Thabut, Chantal Housset, Hélène Fontaine, Stanislas Pol, Fabrice Carrat
Publikováno v:
JHEP Reports, Vol 3, Iss 4, Pp 100298- (2021)
Background & Aims: The Liver Cancer Risk test algorithm (LCR1-LCR2) is a multianalyte blood test combining proteins involved in liver cell repair (apolipoprotein-A1 and haptoglobin), known hepatocellular carcinoma (HCC) risk factors (sex, age, and ga
Externí odkaz:
https://doaj.org/article/2a6493e2f7954175b1cb400a894224aa
Autor:
Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, Valérie Paradis, Valentina Peta, Raluca Pais, Vlad Ratziu, Dominique Thabut, Angelique Brzustowski, Jean-François Gautier, Patrice Cacoub, Dominique Valla
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 699 (2022)
In patients with non-alcoholic fatty liver disease (NAFLD) with or without type 2 diabetes mellitus (T2DM), alpha-2 macroglobulin (A2M), apolipoprotein A1 (ApoA1), and haptoglobin are associated with the risk of liver fibrosis, inflammation (NASH), a
Externí odkaz:
https://doaj.org/article/af76ab0c68d9434ca2827e37a0f595ae
Autor:
Thierry Poynard, Olivier Deckmyn, Marika Rudler, Valentina Peta, Yen Ngo, Mathieu Vautier, Sepideh Akhavan, Vincent Calvez, Clemence Franc, Jean Marie Castille, Fabienne Drane, Mehdi Sakka, Dominique Bonnefont-Rousselot, Jean Marc Lacorte, David Saadoun, Yves Allenbach, Olivier Benveniste, Frederique Gandjbakhch, Julien Mayaux, Olivier Lucidarme, Bruno Fautrel, Vlad Ratziu, Chantal Housset, Dominique Thabut, Patrice Cacoub
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242306 (2020)
BackgroundSince 1920, a decrease in serum cholesterol has been identified as a marker of severe pneumonia. We have assessed the performance of serum apolipoprotein-A1, the main transporter of HDL-cholesterol, to identify the early spread of coronavir
Externí odkaz:
https://doaj.org/article/7670e55a12e8446e9f2a9702b4c12247
Publikováno v:
Annals of Hepatology, Vol 14, Iss 1, Pp 121-126 (2015)
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an
Externí odkaz:
https://doaj.org/article/eb15bf40b14340f8acef03b5a11cded9
Autor:
Valentina Peta, Chantal Tse, Hugo Perazzo, Mona Munteanu, Yen Ngo, An Ngo, Nittia Ramanujam, Lea Verglas, Maxime Mallet, Vlad Ratziu, Dominique Thabut, Marika Rudler, Vincent Thibault, Ina Schuppe-Koistinen, Dominique Bonnefont-Rousselot, Bernard Hainque, Françoise Imbert-Bismut, Michael Merz, Gerd Kullak-Ublick, Raul Andrade, Florian van Boemmel, Eckart Schott, Thierry Poynard, Drug Induced Liver Injury- Groupe Hospitalier Pitié-Salpêtrière, Drug Induced Liver Group of the Injury Safer and Faster Evidence-based Translation consortium
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189436 (2017)
There is a clear need for better biomarkers of drug-induced-liver-injury (DILI).We aimed to evaluate the possible prognostic value of ActiTest and FibroTest proteins apoliprotein-A1, haptoglobin and alpha-2-macroglobulin, in patients with DILI.We ana
Externí odkaz:
https://doaj.org/article/0fbb698e110c4d4ca92f5f00fed29596
Autor:
Thierry Poynard, Olivier Deckmyn, Valentina Peta, Mehdi Sakka, Pascal Lebray, Joseph Moussalli, Raluca Pais, Chantal Housset, Vlad Ratziu, Eric Spasmant, Dominique Thabut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9144da695b4e0b282e0c07bc9ced206
https://doi.org/10.2139/ssrn.4368060
https://doi.org/10.2139/ssrn.4368060
Autor:
Stanislas Pol, Christian Boitard, Nathalie Gault, Jimmy Mullaert, Pauline Manchon, J.M. Castille, Sébastien Czernichow, Thierry Poynard, Jean-François Gautier, Béatrice Parfait, Benoit Terris, Estelle Marcault, Anaïs Vallet-Pichard, Etienne Larger, Valérie Paradis, Cédric Laouénan, F. Drane, Laurent Castera, Valentina Peta, Dominique Valla, Angelique Brzustowski, Olivier Deckmyn, Pierre Bedossa, Nassima Si Mohammed, Mark Ibberson, Dominique Roulot
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 54 (7), pp.952-966. ⟨10.1111/apt.16543⟩
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 54 (7), pp.952-966. ⟨10.1111/apt.16543⟩
Alimentary Pharmacology & Therapeutics
Summary Background One of the unmet needs in patients with type 2 diabetes mellitus (T2DM) is the prediction of non‐alcoholic liver disease by non‐invasive blood tests, for each of the three main histological features, fibrosis, non‐alcoholic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4521b5ffdae4c677d7c9f448add607b4
https://hal.sorbonne-universite.fr/hal-03350034
https://hal.sorbonne-universite.fr/hal-03350034
Autor:
Thierry Poynard, Olivier Deckmyn, An Ngo, Mona Munteanu, Chantal Housset, Frédéric Charlotte, Vlad Ratziu, Valentina Peta, Françoise Imbert-Bismut, Raluca Pais, Denis Monneret, Christian Boitard, Dominique Valla, Yen Ngo, Laurent Castera, Dominique Thabut
Publikováno v:
European Journal of Gastroenterology & Hepatology
Supplemental Digital Content is available in the text.
Objective There is a controversy about the performance of blood tests for the diagnostic of metabolic liver disease in patients with type-2-diabetes in comparison with patients without type-
Objective There is a controversy about the performance of blood tests for the diagnostic of metabolic liver disease in patients with type-2-diabetes in comparison with patients without type-